Jin-long Chen, Chief Scientific Officer at NGM BIOPHARMACEUTICALS INC (NGM), sold 50,000 shares at $19.20 ($945K) on 2020-07-01, disclosed to the SEC on 2020-07-02.
Open-market sale of $945k NGM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.79 | 17,737 | $333K | 35.3% |
| 2 | $18.79 | 17,737 | $333K | 35.3% |
| 3 | $19.20 | 7,263 | $139K | 14.7% |
| 4 | $19.20 | 7,263 | $139K | 14.7% |
| Total | $18.91 avg | 50,000 | $945K | 100% |
| Filing → |
| NGM | SELL | 2021-11-16 | $592K | — | Filing → |
| NGM | SELL | 2021-10-13 | $608K | — | Filing → |
| NGM | SELL | 2021-09-14 | $1.5M | — | Filing → |